LS CancerDiag joins InvestHorizon Accelerator

LS CancerDiag joins InvestHorizon Accelerator

LS CancerDiag joins the InvestHorizon Accelerator, we are delighted to have been accepted to the programme!

InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding. The selected deep tech companies also work on boosting their investment readiness and investor relations.

The selection for this programme is a recognition for the whole team at LS CancerDiag. The timing could not be better as the company is getting ready for its first major funding round.

Joining forces with ambitious investors will enable the company to take the next steps towards its global ambitions. This includes improving processes and increase the laboratory capacity. Furthermore, we’ll extend the team and get ready for the expansion into new markets. The additional resources are essential to drive the growth of DiagMMR® internationally.

The InvestHorizon programme provides support on shaping our message to investors and customers. Also, we’ll have the opportunity to participate in the Tech Tour Contest Final 2019. This platform allows to increase exposure and extend the business network. We are confident that this will take the company a big step forward and provide valuable insights to the team.

Learn more and apply to join the InvestHorizon Accelerator:

Invest today!

LS CancerDiag has launched a funding round in collaboration with Springvest

The company aims to raise €5.4M in capital to support the expansion into the United States and introduce DiagMMR® to the largest health care market in the world.